Fibroblast growth factor receptor
From Proteopedia
(Difference between revisions)
Line 14: | Line 14: | ||
<scene name='54/544712/Cv/2'>Human fibroblast growth factor receptor 1 ligand-binding domain modules D2 and D3 with 2 molecules of fibroblast growth factor 1</scene> (PDB code [[1evt]]). | <scene name='54/544712/Cv/2'>Human fibroblast growth factor receptor 1 ligand-binding domain modules D2 and D3 with 2 molecules of fibroblast growth factor 1</scene> (PDB code [[1evt]]). | ||
+ | |||
+ | ==3D structures of fibroblast growth factor receptor== | ||
+ | [[Fibroblast growth factor receptor 3D receptor]] | ||
+ | |||
</StructureSection> | </StructureSection> | ||
==3D structures of fibroblast growth factor receptor== | ==3D structures of fibroblast growth factor receptor== | ||
Line 24: | Line 28: | ||
*''FGFR1 tyrosine kinase domain residues 458-765'' | *''FGFR1 tyrosine kinase domain residues 458-765'' | ||
+ | **[[4uwy]], [[6mzq]] – hFGFR1 TKD - human<br /> | ||
**[[1fgk]], [[3kxx]], [[3ky2]], [[4rwi]], [[5flf]] – hFGFR1 TKD (mutant) - human <br /> | **[[1fgk]], [[3kxx]], [[3ky2]], [[4rwi]], [[5flf]] – hFGFR1 TKD (mutant) - human <br /> | ||
- | + | **[[4wun]], [[5am6]], [[5ew8]], [[5o49]], [[5o4a], [[6mzw]], [[6c1o]] – hFGFR1 TKD + inhibitor <br /> | |
- | **[[4wun]], [[5am6]], [[5ew8]], [[5o49]], [[ | + | **[[1agw]], [[1fgi]], [[2fgi]], [[3c4f]], [[3js2]], [[3rhx]], [[4f63]], [[4f64]], [[4f65]], [[3tt0]], [[4nk9]], [[4nka]], [[4nks]], [[5b7v]], [[5am7]], [[4rwj]], [[4rwk]], [[4rwl]], [[4uwb]], [[4uwc]], [[4zsa]], [[5uq0]], [[5vnd]], [[5ur1]], [[6p68]], [[6p69]], [[6c18]], [[6c19]], [[6c1b]], [[6c1c]], [[5z0s]] – hFGFR1 TKD (mutant) + inhibitor <br /> |
- | **[[1agw]], [[1fgi]], [[2fgi]], [[3c4f]], [[3js2]], [[3rhx]], [[4f63]], [[4f64]], [[4f65]], [[3tt0]], [[4nk9]], [[4nka]], [[4nks]], [[5b7v]], [[5am7]], [[4rwj]], [[4rwk]], [[4rwl]], [[4uwb]], [[4uwc]], [[4zsa]], [[5uq0]], [[5vnd]], [[5ur1]] | + | **[[5zv2]] – hFGFR1 TKD (mutant) + anti-cancer drug<br /> |
**[[3krj]] – hFGFR1 TKD residues 538-678, 753-922 (mutant) + inhibitor <br /> | **[[3krj]] – hFGFR1 TKD residues 538-678, 753-922 (mutant) + inhibitor <br /> | ||
**[[1xr0]] – hFGFR1 residues 409-430 + FGFR signaling adaptor N terminal - NMR<br /> | **[[1xr0]] – hFGFR1 residues 409-430 + FGFR signaling adaptor N terminal - NMR<br /> | ||
Line 98: | Line 103: | ||
**[[4qqj]], [[4qqt]] – hFGFR4 TKD (mutant) <br /> | **[[4qqj]], [[4qqt]] – hFGFR4 TKD (mutant) <br /> | ||
**[[5jkg]], [[5nwz]], [[5nud]] – hFGFR4 TKD + inhibitor<br /> | **[[5jkg]], [[5nwz]], [[5nud]] – hFGFR4 TKD + inhibitor<br /> | ||
+ | **[[6jpj]], [[5xff]], [[5xfj]] – hFGFR4 TKD (mutant) + inhibitor<br /> | ||
**[[4qrc]], [[4r6v]], [[4qqc]], [[4qq5]], [[4uxq]], [[4xcu]] – hFGFR4 TKD (mutant) + irreversible inhibitor<br /> | **[[4qrc]], [[4r6v]], [[4qqc]], [[4qq5]], [[4uxq]], [[4xcu]] – hFGFR4 TKD (mutant) + irreversible inhibitor<br /> | ||
Revision as of 07:54, 1 July 2019
|
3D structures of fibroblast growth factor receptor
Updated on 01-July-2019 {{#tree:id=OrganizedByTopic|openlevels=0|
- FGFR1
- FGFR1 tyrosine kinase domain residues 458-765
- 4uwy, 6mzq – hFGFR1 TKD - human
- 1fgk, 3kxx, 3ky2, 4rwi, 5flf – hFGFR1 TKD (mutant) - human
- 4wun, 5am6, 5ew8, 5o49, [[5o4a], 6mzw, 6c1o – hFGFR1 TKD + inhibitor
- 1agw, 1fgi, 2fgi, 3c4f, 3js2, 3rhx, 4f63, 4f64, 4f65, 3tt0, 4nk9, 4nka, 4nks, 5b7v, 5am7, 4rwj, 4rwk, 4rwl, 4uwb, 4uwc, 4zsa, 5uq0, 5vnd, 5ur1, 6p68, 6p69, 6c18, 6c19, 6c1b, 6c1c, 5z0s – hFGFR1 TKD (mutant) + inhibitor
- 5zv2 – hFGFR1 TKD (mutant) + anti-cancer drug
- 3krj – hFGFR1 TKD residues 538-678, 753-922 (mutant) + inhibitor
- 1xr0 – hFGFR1 residues 409-430 + FGFR signaling adaptor N terminal - NMR
- 3gqi – hFGFR1 TKD (mutant) with PTR + ACP
- 3gql – hFGFR1 TKD (mutant) + substrate
- 4uwy, 6mzq – hFGFR1 TKD - human
- FGFR1 ligand-binding domain D1 residues 35-208
- FGFR1 D1 complex with FGF
- 5w59 – hFGFR1 LBD D1 + FGF9
- 5w59 – hFGFR1 LBD D1 + FGF9
- FGFR1 D2,D3 residues 142-365 complex with FGF
- FGFR2
- FGFR2 tyrosine kinase domain
- 1gjo, 1oec, 2psq – hFGFR2 TKD
- 2pvy, 2pwl, 2py3, 2pz5, 2pzp, 2pzr, 2q0b, 4j95, 4j96, 4j97, 4j98, 4j99, 5ugx, 5uhn, 5ui0 – hFGFR2 TKD (mutant) + ACP
- 5ugl – hFGFR2 TKD (mutant) + ANP
- 3b2t – hFGFR2 TKD (mutant) + adenosine derivative
- 2pvf – hFGFR2 TKD with PTR + ACP + substrate peptide
- 3cly – hFGFR2 TKD (mutant) with PTR + ACP
- 5eg3 – hFGFR2 TKD (mutant) with PTR + ACP + phospholipase C γ
- 3ri1 – hFGFR2 TKD + inhibitor
- 1gjo, 1oec, 2psq – hFGFR2 TKD
- FGFR2 ligand-binding domain
- FGFR2 complex with FGF
- 1e0o – hFGFR2 (mutant) LBD D2,D3 + hFGF1 (mutant) + HS
- 3oj2, 3ojm – hFGFR2 (mutant) LBD D2,D3 + hFGF1
- 1djs – hFGFR2 LBD D2,D3 (mutant) + hFGF1
- 1ev2, 1ii4, 1iil – hFGFR2 LBD D2,D3 + hFGF2 (mutant)
- 4j23 – hFGFR2 LBD D2,D3 (mutant) + hFGF2 (mutant) + inhibitor
- 3cu1 – hFGFR2 LBD D2 + hFGF1
- 2fdb – hFGFR2 LBD D2,D3 + hFGF8b
- 1nun – hFGFR2 LBD D2,D3 + hFGF10
- 1e0o – hFGFR2 (mutant) LBD D2,D3 + hFGF1 (mutant) + HS
- FGFR3
- FGFR3 complex with FGF
- 1ry7 – hFGFR3 LBD + hFGF1
- 1ry7 – hFGFR3 LBD + hFGF1
- FGFR4
- FGFR4 tyrosine kinase domain
}}
References
- ↑ Coutts JC, Gallagher JT. Receptors for fibroblast growth factors. Immunol Cell Biol. 1995 Dec;73(6):584-9. PMID:8713482 doi:http://dx.doi.org/10.1038/icb.1995.92
- ↑ Wilkin DJ, Szabo JK, Cameron R, Henderson S, Bellus GA, Mack ML, Kaitila I, Loughlin J, Munnich A, Sykes B, Bonaventure J, Francomano CA. Mutations in fibroblast growth-factor receptor 3 in sporadic cases of achondroplasia occur exclusively on the paternally derived chromosome. Am J Hum Genet. 1998 Sep;63(3):711-6. PMID:9718331 doi:http://dx.doi.org/10.1086/302000
- ↑ Intini D, Baldini L, Fabris S, Lombardi L, Ciceri G, Maiolo AT, Neri A. Analysis of FGFR3 gene mutations in multiple myeloma patients with t(4;14). Br J Haematol. 2001 Aug;114(2):362-4. PMID:11529856
- ↑ Meyers GA, Orlow SJ, Munro IR, Przylepa KA, Jabs EW. Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans. Nat Genet. 1995 Dec;11(4):462-4. PMID:7493034 doi:http://dx.doi.org/10.1038/ng1295-462